Heron Therapeutics Inc (USD)
HRTX
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range15.32 | 16.44
52-Wk Range- | -
Last Close16.04
Mkt Cap (m)1,453.90
Dividend yield-
ISINUS4277461020
Volume1,707,825.00
Exchange VenueNAS

Company Profile

Heron Therapeutics Inc is a biotechnology company, developing products to address unmet medical needs. It is developing novel, patient-focused solutions that apply its science and technologies to already-approved pharmacological agents.

Key Information
Price/Earning-
Price/Book3.98
Price/Sales9.73
P/CF-
Rev Growth (3 year avg)385.06
EPS Growth (3 year avg)-
Operating Margin % -144.34
Net Margin %-140.27
Return on Equity-52.91
Debt/Equity0.05

Documents

Prospectus
en 07/10/2019
Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

http://www.herontx.com

Financials

Income Statement
USD201420152016201720182019
Revenue (m)0.000.001.2830.7777.47145.97
Operating Income (m)-74.56-96.93-170.92-194.56-183.94-210.69
Net Income (m)-76.37-97.59-173.14-197.48-178.84-204.75
Basic EPS-2.87-2.95-4.56-3.65-2.44-2.50
Avg. Diluted Shares Outstanding (m)26.5733.0837.9354.0473.1981.78
Balance Sheet
USD201420152016201720182019
Current Assets (m)73.73134.7562.14228.06447.25479.06
Non Current Assets (m)2.953.095.346.2414.9333.72
Total Assets (m)76.68137.8567.48234.31462.18512.78
Current Liabilities (m)13.6219.7438.73103.1792.0296.71
Total Liabilities (m)------
Total Equity (m)63.06118.11-21.25131.14370.16403.84
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)-60.28-78.53-134.10-170.30-191.81-124.58
Capital Expenditure (m)-1.44-1.09-3.14-2.55-9.17-7.15
Figures are quoted in USD unless stated otherwise
-0.22 (-1.34%)
$
15.83
Last Price